drug

piflufolastat

1 story · latest Nov 5, 2026

Follow piflufolastat. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Novartis

Timeline

Lantheus reports Q3 2026 results, gains two approvals amid pending Curium merger

Nov 5Quarterly updateflorquinitau f-18 Lantheus Holdings, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.